Lupin Limited has informed the Exchange regarding a press release dated January 04, 2024, titled "Lupin Receives Tentative Approval from U.S. FDA for Dapagliflozin and SaxagliptinTablets.".
Lupin Limited has informed the Exchange regarding a press release dated January 04, 2024, titled "Lupin Receives Tentative Approval from U.S. FDA for Dapagliflozin and SaxagliptinTablets.".